UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma

BACKGROUND: To discover biomarker panels that could distinguish cancers (BC and RCC) from healthy controls (HCs) and bladder cancers (BC) from renal cell carcinoma (RCC), regardless of whether the patients have haematuria. In addition, we also explored the altered metabolomic pathways of BC and RCC....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhan, Liu, Xiaoyan, Liu, Xiang, Sun, Haidan, Guo, Zhengguang, Zheng, Guoyang, Zhang, Yushi, Sun, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896793/
https://www.ncbi.nlm.nih.gov/pubmed/31805976
http://dx.doi.org/10.1186/s12885-019-6354-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896793/
https://www.ncbi.nlm.nih.gov/pubmed/31805976
http://dx.doi.org/10.1186/s12885-019-6354-1

Ejemplares similares